Literature DB >> 21860463

The transcription factor FOXM1 is a cellular target of the natural product thiostrepton.

Nagaratna S Hegde1, Deborah A Sanders, Raphaël Rodriguez, Shankar Balasubramanian.   

Abstract

Transcription factors are proteins that bind specifically to defined DNA sequences to promote gene expression. Targeting transcription factors with small molecules to modulate the expression of certain genes has been notoriously difficult to achieve. The natural product thiostrepton is known to reduce the transcriptional activity of FOXM1, a transcription factor involved in tumorigenesis and cancer progression. Herein we demonstrate that thiostrepton interacts directly with FOXM1 protein in the human breast cancer cells MCF-7. Biophysical analyses of the thiostrepton-FOXM1 interaction provide additional insights on the molecular mode of action of thiostrepton. In cellular experiments, we show that thiostrepton can inhibit the binding of FOXM1 to genomic target sites. These findings illustrate the potential druggability of transcription factors and provide a molecular basis for targeting the FOXM1 family with small molecules.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21860463     DOI: 10.1038/nchem.1114

Source DB:  PubMed          Journal:  Nat Chem        ISSN: 1755-4330            Impact factor:   24.427


  44 in total

Review 1.  The emerging roles of forkhead box (Fox) proteins in cancer.

Authors:  Stephen S Myatt; Eric W-F Lam
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

2.  Synthesis of diverse lactam carboxamides leading to the discovery of a new transcription-factor inhibitor.

Authors:  Pui Yee Ng; Yuchen Tang; Wendy M Knosp; H Scott Stadler; Jared T Shaw
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

3.  The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo.

Authors:  D Weigel; G Jürgens; F Küttner; E Seifert; H Jäckle
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

4.  Over-expression of FoxM1 stimulates cyclin B1 expression.

Authors:  T W Leung; S S Lin; A C Tsang; C S Tong; J C Ching; W Y Leung; R Gimlich; G G Wong; K M Yao
Journal:  FEBS Lett       Date:  2001-10-19       Impact factor: 4.124

5.  Antibiotic susceptibility of mammalian mitochondrial translation.

Authors:  Li Zhang; Ng Ching Ging; Taeko Komoda; Takao Hanada; Tsutomu Suzuki; Kimitsuna Watanabe
Journal:  FEBS Lett       Date:  2005-11-02       Impact factor: 4.124

6.  Regulation of gene expression by small molecules.

Authors:  J M Gottesfeld; L Neely; J W Trauger; E E Baird; P B Dervan
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

7.  Induction of human epithelial stem/progenitor expansion by FOXM1.

Authors:  Emilios Gemenetzidis; Daniela Elena-Costea; Eric K Parkinson; Ahmad Waseem; Hong Wan; Muy-Teck Teh
Journal:  Cancer Res       Date:  2010-11-09       Impact factor: 12.701

8.  Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain.

Authors:  K M Yao; M Sha; Z Lu; G G Wong
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

9.  FoxM1 is a general target for proteasome inhibitors.

Authors:  Uppoor G Bhat; Marianna Halasi; Andrei L Gartel
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

View more
  117 in total

1.  Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.

Authors:  Lizhu Jiang; Xiaosong Wu; Peng Wang; Taoyu Wen; Chao Yu; Lei Wei; Hongyan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-13       Impact factor: 4.553

2.  FoxM1: a potential drug target for glioma.

Authors:  Yu Li; Sicong Zhang; Suyun Huang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

3.  Thiostrepton, proteasome inhibitors and FOXM1.

Authors:  Andrei L Gartel
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

Review 4.  Unravelling the genomic targets of small molecules using high-throughput sequencing.

Authors:  Raphaël Rodriguez; Kyle M Miller
Journal:  Nat Rev Genet       Date:  2014-10-14       Impact factor: 53.242

5.  Characterization of a novel plasmid-borne thiopeptide gene cluster in Staphylococcus epidermidis strain 115.

Authors:  Philip R Bennallack; Scott R Burt; Michael J Heder; Richard A Robison; Joel S Griffitts
Journal:  J Bacteriol       Date:  2014-10-13       Impact factor: 3.490

Review 6.  Targeting forkhead box M1 transcription factor in breast cancer.

Authors:  Ruth M O'Regan; Rita Nahta
Journal:  Biochem Pharmacol       Date:  2018-05-31       Impact factor: 5.858

7.  Expression of FOXM1 and related proteins in breast cancer molecular subtypes.

Authors:  Jeong-Ju Lee; Hee Jin Lee; Byung-Ho Son; Sung-Bae Kim; Jin-Hee Ahn; Seung Do Ahn; Eun Yoon Cho; Gyungyub Gong
Journal:  Int J Exp Pathol       Date:  2016-06-09       Impact factor: 1.925

Review 8.  Elucidating and engineering thiopeptide biosynthesis.

Authors:  Philip R Bennallack; Joel S Griffitts
Journal:  World J Microbiol Biotechnol       Date:  2017-05-11       Impact factor: 3.312

Review 9.  Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions.

Authors:  Leah N Makley; Jason E Gestwicki
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

10.  Identification of master regulator genes of UV response and their implications for skin carcinogenesis.

Authors:  Yao Shen; Gabriel Chan; Michael Xie; Wangyong Zeng; Liang Liu
Journal:  Carcinogenesis       Date:  2019-07-04       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.